nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
BMS-663068, a safe and effective HIV-1 attachment inhibitor
|
Ballana, Ester |
|
2015 |
2 |
10 |
p. e404-e405 nvt p. |
artikel |
2 |
Causes of hospital admission among people living with HIV worldwide: a systematic review and meta-analysis
|
Ford, Nathan |
|
2015 |
2 |
10 |
p. e438-e444 nvt p. |
artikel |
3 |
Corrections
|
|
|
2015 |
2 |
10 |
p. e416- 1 p. |
artikel |
4 |
Corrections
|
|
|
2015 |
2 |
10 |
p. e416- 1 p. |
artikel |
5 |
Effect of low-threshold methadone maintenance therapy for people who inject drugs on HIV incidence in Vancouver, BC, Canada: an observational cohort study
|
Ahamad, Keith |
|
2015 |
2 |
10 |
p. e445-e450 nvt p. |
artikel |
6 |
Enhancing efforts to address infections
|
Luz, Paula M |
|
2015 |
2 |
10 |
p. e406-e407 nvt p. |
artikel |
7 |
HIV viral load messages should go viral in India
|
Isaakidis, Petros |
|
2015 |
2 |
10 |
p. e414-e415 nvt p. |
artikel |
8 |
Is it time to abandon single intervention cure trials?
|
Ananworanich, Jintanat |
|
2015 |
2 |
10 |
p. e410-e411 nvt p. |
artikel |
9 |
Is monotherapy maintenance the way forward?
|
Calmy, Alexandra |
|
2015 |
2 |
10 |
p. e402-e403 nvt p. |
artikel |
10 |
Liver disease in patients with HIV in sub-Saharan Africa
|
Cainelli, Francesca |
|
2015 |
2 |
10 |
p. e412-e413 nvt p. |
artikel |
11 |
Methadone treatment in primary care
|
Wu, Zunyou |
|
2015 |
2 |
10 |
p. e408-e409 nvt p. |
artikel |
12 |
PrEP: why are we waiting?
|
The Lancet HIV, |
|
2015 |
2 |
10 |
p. e401- 1 p. |
artikel |
13 |
Protease inhibitor monotherapy for long-term management of HIV infection: a randomised, controlled, open-label, non-inferiority trial
|
Paton, Nicholas I |
|
2015 |
2 |
10 |
p. e417-e426 nvt p. |
artikel |
14 |
Safety and efficacy of the HIV-1 attachment inhibitor prodrug BMS-663068 in treatment-experienced individuals: 24 week results of AI438011, a phase 2b, randomised controlled trial
|
Lalezari, Jacob P |
|
2015 |
2 |
10 |
p. e427-e437 nvt p. |
artikel |